Results 41 to 50 of about 326,590 (304)

Identification and profiling of HLA-A*02:01-restricted Toxoplasma gondii peptides through immunopeptidomics in HLA-A2.1 transgenic mice

open access: yesVirulence
HLA class I presentation of pathogen-derived peptides is essential for CD8+ T-cell recognition of Toxoplasma gondii. While in vitro MHC ligands have been documented, the in vivo ligandome during infection progression remains poorly characterized.
Ruiying Liang   +10 more
doaj   +1 more source

Advances in the Characterization of the T-Cell Response to Human Herpesvirus-6

open access: yesFrontiers in Immunology, 2018
Human herpesvirus (HHV) 6 is thought to remain clinically latent in most individuals after primary infection and to reactivate to cause disease in persons with severe immunosuppression.
Derek J. Hanson   +8 more
doaj   +1 more source

Thermal and Acidic Treatments of Gluten Epitopes Affect Their Recognition by HLA-DQ2 in silico

open access: yesFrontiers in Nutrition, 2021
Celiac disease (CD) is a prevalent disorder with autoimmune features. Dietary exposure of wheat gluten (including gliadins and glutenins) to the small intestine activates the gluten-reactive CD4+ T cells and controls the disease development.
Jihui Gao   +13 more
doaj   +1 more source

Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection

open access: yesFrontiers in Immunology, 2018
Zika virus (ZIKV) has recently caused explosive outbreaks in Pacific islands, South- and Central America. Like with other flaviviruses, protective immunity is strongly dependent on potently neutralizing antibodies (Abs) directed against the viral ...
Maximilian Koblischke   +8 more
doaj   +1 more source

Epitope-specific antibody responses in gD2 immunized guinea pigs and humans.

open access: yes, 2018
Epitope-specific antibody responses in gD2 immunized guinea pigs and humans.
Harvey M. Friedman (3682018)   +7 more
core   +1 more source

The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus

open access: yesVaccines, 2022
After the outbreak of SARS-CoV-2 by the end of 2019, the vaccine development strategies became a worldwide priority. Furthermore, the appearances of novel SARS-CoV-2 variants challenge researchers to develop new pharmacological or preventive strategies ...
Jazmín García-Machorro   +3 more
doaj   +1 more source

Epitope spreading

open access: yesCurrent Opinion in Immunology, 1996
Epitope (determinant) spreading is the development of immune responses to endogenous epitopes secondary to the release of self antigens during a chronic autoimmune or inflammatory response. The past year has seen considerable advances in our understanding of the contribution of epitope spreading to the chronic pathogenesis of experimental T-cell ...
Vanderlugt, Carol J, Miller, Stephen D
openaire   +2 more sources

A Method for Screening Proteases That Can Specifically Hydrolyze the Epitope AA83-105 of αs1-Casein Allergen

open access: yesFoods, 2022
Milk protein hydrolysates are common in infant formula, but some of them retain allergenicity due to incomplete hydrolysis of the epitopes for milk allergens.
Di Liu   +3 more
doaj   +1 more source

Generation and characterization of a recombinant Rift Valley fever virus expressing a V5 epitope-tagged RNA-dependent RNA polymerase [PDF]

open access: yes, 2011
The viral RNA-dependent RNA polymerase (RdRp; L protein) of Rift Valley fever virus (RVFV; family Bunyaviridae) is a 238 kDa protein that is crucial for the life cycle of the virus, as it catalyses both transcription of viral mRNAs and replication of the
Brennan, Benjamin   +5 more
core   +1 more source

Epitope-tagged Edis-p and Relish co-localize in S2 cells.

open access: yes, 2022
S2 cells were transfected with various combinations of pMT, pMT-Flag-Edis-p and pMT-Relish-HA constructs, as indicated on the left. Epitope-tagged proteins were visualized by staining with antibodies against Flag (green) and HA (red) epitopes.
Shiyu Xu (9662931)   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy